Where is Evia Bio located?

Evia Bio is headquartered in Minneapolis, United States.

How many employees does Evia Bio have?

As of Sep 30, 2026, the latest employee count at Evia Bio is 10.

Where does Evia Bio rank among its competitors?

Evia Bio ranks 9th amongst 36 active competitors, of which 5 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Genepoint Biological Technology, which secured $29.5M in Jan, 2023.

Who are the top competitors of Evia Bio?

Evia Bio's top competitors include Stirling Ultracold, Vitrafy and Genepoint Biological Technology. Among them, Genepoint Biological Technology secured the most recent funding round in January, 2023.

Evia Bio - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of cryopreservation technology for the cell therapy supply chain. It offers non-DMSO cryopreservation solutions that stabailize and protect the integrity of cells during cryopreservation of cell therapy during supply chain.

Key Metrics

Founded Year

2021

Location

Minneapolis, United States

Stage

Funding Raised

Investors

Pleasant Bay Capital Partners

Ranked

9^th among 36 active competitors

Employee Count

10 as on Sep 30, 2026

Similar Companies

Stirling Ultracold & 34 more

View Evia Bio's full profile

Evia Bio is a funded company. Evia Bio has 1 institutional investor.

View details of Evia Bio's funding rounds and investors

The founders of Evia Bio is Allison Hubel. Jeffrey Allen is the CEO of Evia Bio.

Here are the details of Evia Bio's key team members:

Allison Hubel: Founder and CSO of Evia Bio.

View details of Evia Bio's Founder profiles and Board Members

Evia Bio's employee count trend

Evia Bio has 10 employees as of Sep 26. Here is Evia Bio's employee count trend over the years:

Uncover Evia Bio's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Evia Bio include Stirling Ultracold, Vitrafy and Genepoint Biological Technology. Here is the list of Top 10 competitors of Evia Bio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Stirling Ultracold 2009, Athens (United States), Acquired	Manufacturer of freezer for storage and preservation	$8.7M	Ohio Innovation Fund, Square 1 Bank & 5 others	58/100
2nd	Vitrafy 2018, Ballarat (Australia), Public	Developer of cryopreservation system for human blood products and advanced cellular therapies	-	-	43/100
3rd	Genepoint Biological Technology 2015, Shanghai (China), Series D	Platform for cryostorage and long-term preservation	$48.3M	NLVC, New Hope Group & 8 others	39/100
4th	Montana Instruments 2008, Bozeman (United States), Acquired	Cryogenic solutions provider accelerating quantum discovery with reliable, low-temperature environments	-	-	39/100
5th	PanTHERA CryoSolutions 2018, Edmonton (Canada), Acquired	Provider of a platform for cell cryopreservation	$6M	Casdin Capital, BioLife Solutions & 1 others	38/100
6th	Cryopal 1968, Bussy Saint Georges (France), Funding Raised	Provider of cryo-preservation equipment and services	-	Initiative & Finance	35/100
7th	Cell Matters 2017, Liege (Belgium), Series A	CDMO focused on manufacturing of cell therapy products	$872K	Paip investissements, Noshaq & 2 others	34/100
8th	HOHCells College Park (United States), Unfunded	Manufacturer of cryopreservation technology for stress sensitive biological cell samples	-	-	32/100
9th	Evia Bio 2021, Minneapolis (United States), Funding Raised	Provider of cryopreservation technology for the cell therapy supply chain	-	Pleasant Bay Capital Partners	31/100
10th	Biolinx India 2008, Thane (India), Unfunded	Provider of laboratory equipment for storage of pharmaceutical research products	-	-	29/100